Assertio Therapeutics Inc (ASRT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2010 | 12-2009 | 12-2008 | 12-2007 | 12-2006 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 22,526 | 26,821 | 22,127 | 14,374 | 14,574 |
| Marketable Securities | 47,825 | 42,922 | 59,932 | 39,091 | 16,985 |
| Receivables | 6,347 | 4,933 | 3,675 | 3,623 | 9,082 |
| Inventories | 1,571 | 2,565 | 2,849 | 3,263 | 4,483 |
| TOTAL | $79,599 | $78,426 | $93,987 | $62,769 | $47,880 |
| Non-Current Assets | |||||
| PPE Net | 698 | 942 | 900 | 1,621 | 2,541 |
| Investments And Advances | 6,537 | 12,016 | 0 | 16,058 | 1,999 |
| Other Non-Current Assets | 197 | 197 | 197 | 197 | 197 |
| TOTAL | $7,432 | $13,155 | $1,097 | $17,876 | $4,737 |
| Total Assets | $87,031 | $91,581 | $95,084 | $80,645 | $52,617 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 2,170 | 3,747 | 3,356 | N/A | N/A |
| Accounts payable and accrued liabilities | 18,473 | 15,222 | 12,848 | 1,134 | 4,886 |
| Accrued Expenses | N/A | N/A | N/A | 1,880 | 4,884 |
| Other current liabilities | 635 | 414 | N/A | 56 | 56 |
| TOTAL | $32,984 | $32,202 | $22,378 | $14,334 | $22,339 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | 2,170 | 5,775 | N/A | N/A |
| Deferred Revenues | 11,706 | 12,819 | 6,064 | 7,942 | 9,425 |
| Other Non-Current Liabilities | 15 | 177 | 569 | 28 | 84 |
| TOTAL | $30,941 | $43,653 | $39,553 | $20,791 | $57,567 |
| Total Liabilities | $63,925 | $75,855 | $61,931 | $35,125 | $79,906 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 893 | 873 | 854 | 798 | 702 |
| Common Shares | 191,343 | 187,895 | 183,196 | 168,287 | 144,820 |
| Retained earnings | -168,306 | -172,202 | -150,194 | -134,892 | -184,111 |
| Other shareholders' equity | 69 | 33 | 151 | 12,125 | 12,002 |
| TOTAL | $23,106 | $15,726 | $33,153 | $45,520 | $-27,289 |
| Total Liabilities And Equity | $87,031 | $91,581 | $95,084 | $80,645 | $52,617 |